BROOKE MAPLE: Open Payments
NPI 1780932319 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 58 payments from 18 companies in 2025. Trend: 2023 $858 · 2024 $863 · 2025 $1,126
Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $167 |
| Teva Pharmaceuticals USA, Inc. | 8 | $137 |
| ABBVIE INC. | 12 | $136 |
| Janssen Pharmaceuticals, Inc | 5 | $116 |
| Alkermes, Inc. | 5 | $98 |
| Axsome Therapeutics, Inc. | 5 | $94 |
| Lundbeck LLC | 3 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Neurocrine BioSciences, Inc. | 3 | $47 |
| Bausch Health US, LLC | 2 | $41 |
Products named: Wegovy, VRAYLAR, Auvelity, INVEGA SUSTENNA, AUSTEDO XR, REXULTI, ARISTADA, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
